Table 2. Occurrence of opportunistic... | American Society of Hematology

Table 2.

Occurrence of opportunistic infections

	Type of infection	Mo of onset	CD4⁺CD3⁺ cells,^*cells/mm³	Treatment
CD34⁺-selected group
Patient 4	VZV pancreatitis	24	234	Acyclovir
Patient 9	PCC pneumonia	4	149	Cotrimoxazole
Patient 9	HSV esophagitis	4	149	Acyclovir
Patient 11	VZV varicella	9	308	Acyclovir
Patient 14	VZV varicella	3	81	Acyclovir
Patient 22	VZV retinitis	8	163	Acyclovir
Unselected group
Patient 13	CNS toxoplasmosis	9	480	Pyrimethamine-sulfadiazine
Patient 17	HSV pneumonia	4	444	Acyclovir
Patient 28	VZV zoster	4	508	Acyclovir

	Type of infection	Mo of onset	CD4⁺CD3⁺ cells,^*cells/mm³	Treatment
CD34⁺-selected group
Patient 4	VZV pancreatitis	24	234	Acyclovir
Patient 9	PCC pneumonia	4	149	Cotrimoxazole
Patient 9	HSV esophagitis	4	149	Acyclovir
Patient 11	VZV varicella	9	308	Acyclovir
Patient 14	VZV varicella	3	81	Acyclovir
Patient 22	VZV retinitis	8	163	Acyclovir
Unselected group
Patient 13	CNS toxoplasmosis	9	480	Pyrimethamine-sulfadiazine
Patient 17	HSV pneumonia	4	444	Acyclovir
Patient 28	VZV zoster	4	508	Acyclovir

VZV indicates varicella zoster virus; PCC, Pneumocystis carinii; HSV, herpes simplex virus; and CNS, central nervous system.

Evaluated at the time or in the month before the onset of infection.